<DOC>
	<DOCNO>NCT01492907</DOCNO>
	<brief_summary>Study Design : This single institution pilot study recruit 4 patient operable pancreatic cancer schedule pancreatectomy 4 age/sex match normal control . Both group receive single oral dose radiolabeled MelQx follow serial blood draw 8 hour period urine collection 24 hour period . In addition , normal pancreatic tissue normal small bowel tissue collect Tissue Procurement resect ( waste ) tissue time pancreatectomy 4 pancreatic cancer patient .</brief_summary>
	<brief_title>Pilot Study Meat-Borne Carcinogens Pancreatic Cancer</brief_title>
	<detailed_description>This therapeutic trial . It etiologic investigation meat-borne carcinogen possible role pancreatic cancer .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Cancer case eligible participation follow criterion meet : 1 . Diagnosis suspect diagnosis pancreatic periampullary cancer deem operable pancreatectomy plan . At least 18 year age . Adequate hepatic function within 4 week study enrollment define : Bilirubin ≤ 2 mg/dl aspartate aminotransferase ( ALT ) , alanine aminotransferase ( AST ) , alkaline phosphatase ≤ 2 upper limit normal ( ULN ) Females childbearing potential male whose partner child bear potential require use effective method contraception ( ie , hormonal contraceptive , intrauterine device , diaphragm spermicide , condom spermicide , abstinence ) study 2 week MelQx administration . Voluntary write consent performance studyrelated procedure part normal medical care Healthy control eligible participation follow criterion meet : Consider generally healthy . At least 18 year age Controls gender age match within 10 year case . Adequate hepatic function within 4 week study enrollment define : Bilirubin ≤ 2 mg/dl ALT , AST , alkaline phosphatase ≤ 2 upper limit normal ( ULN ) Females childbearing potential male whose partner child bear potential require use effective method contraception ( ie , hormonal contraceptive , intrauterine device , diaphragm spermicide , condom spermicide , abstinence ) study 2 week MelQx administration . Voluntary write consent performance studyrelated procedure part normal medical care Cancer case eligible participation follow criterion meet : For purpose study reduce risk recruit potentially unresectable patient : Tumor ≥ 3 cm scan CA199 &gt; 400 Ascites Pregnant lactate Uncontrolled chronic condition : cardiovascular disease , hypertension , angina , congestive obstructive pulmonary disease ( COPD ) condition may alter metabolism , diabetes . Healthy control eligible participation follow criterion meet : Pregnant lactating . Uncontrolled chronic condition cardiovascular disease , hypertension , angina , COPD condition may alter metabolism include diabetes .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Heterocyclic amine carcinogen</keyword>
	<keyword>meat-borne carcinogen</keyword>
</DOC>